T

Transpek Industry Limited

TRANSPEK
Market snapshot · 2026-08-11 09:19 UTC

1,180.00

₹-52.60 (-4.27%)

MARKET CAP

₹659.10 Cr

STOCK P/E

14.4x

52W HIGH

₹1,447.90

52W LOW

₹952.30

BOOK VALUE

₹1,374.42

EPS

₹81.68

ROE

SECTOR

Materials

DEBT/EQUITY

VOLUME

1,210

P/B RATIO

0.86x

PEG RATIO

Sector

Materials

Themes

Commodity ChemicalsMukul Agrawal Portfolio
₹1,262.40₹1,191.69₹1,120.98₹1,050.26₹979.55VolumeApr '26May '26May '26Jun '26Jun '26Jul '26Jul '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 10.8% above historical median. Valuation is stable — currently in the strongly overvalued zone (z-score: +0.91). Confidence: 92%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Overvalued

5Y Average

13.87

Current

14.45

Overvalued

14.45

Undervalued

12.43

P/B
Fair

5Y Average

0.82

Current

0.86

Overvalued

0.95

Undervalued

0.70

P/S
Fair

5Y Average

1.04

Current

1.08

Overvalued

1.19

Undervalued

0.88

Peers & Comparison

Sector: Commodities

Chemicals Peers8 peers
Avg P/E: 24.2x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
18.4x
Undervalued
-24% vs avg
6.7x
Undervalued
-72% vs avg
25.8x
Fair
+7% vs avg
ALCODIS
ALCODISChemicals
ANYA
ANYAChemicals
BIOPOL
BIOPOLChemicals
SRF LTD
SRFChemicals
+31.8%12.7%
35.3x
Premium
+46% vs avg
-8.3%
AARTI INDUSTRIES LTD
AARTIINDChemicals
+42.5%5.9%
34.6x
Premium
+43% vs avg
+35.0%
WHY THESE PEERS

Comparable-scale peer data is limited — showing nearest stored business/industry peers instead of an empty comparison.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹148 CrMar 2026

Latest net profit

₹7.00 CrMar 2026

Latest EPS

₹11.78Mar 2026

Net margin

4.1%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%3.0%6.0%9.0%12.0%0.00 Cr45 Cr90 Cr135 Cr180 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr45 Cr90 Cr135 Cr180 Cr₹0₹9₹18₹27₹36
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit-50 Cr0.00 Cr50 Cr100 Cr150 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Sep 2025Mar 20260.00 Cr300 Cr600 Cr900 Cr1.20K Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹148 Cr

-10.3%

Net Profit

₹7 Cr

-65.8%

EBITDA

₹22 Cr

-44.9%

EPS

₹11.78

-65.7%
MetricMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales165154160158148
Expenses146143146146142
Operating Profit201214136
OPM %11.84%7.6%8.95%7.94%4.1%
Other Income812544
Interest32222
Depreciation1312121212
Profit before tax252117149
Tax %21.5%25.56%25.51%25.01%25.51%
Net Profit191613117
EPS in Rs34.3927.9022.6219.4211.78

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters57.47%57.47%57.47%57.47%57.47%
FII0.03%0.04%0.03%0.03%0.02%
DII1.79%1.76%1.57%1.57%1.53%
Public31.38%30.51%31.03%31.22%31.17%
Others9.33%10.22%9.90%9.71%9.81%
Mar 2026
Promoters
FII
DII
Public
Others